Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Change in Cash (2020 - 2023)

Historic Change in Cash for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to $42.0 million.

  • Terns Pharmaceuticals' Change in Cash fell 4762.77% to $42.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$63.3 million, marking a year-over-year decrease of 16626.72%. This contributed to the annual value of $81.5 million for FY2024, which is 22875.42% up from last year.
  • As of Q4 2023, Terns Pharmaceuticals' Change in Cash stood at $42.0 million, which was down 4762.77% from -$43.0 million recorded in Q3 2023.
  • Over the past 5 years, Terns Pharmaceuticals' Change in Cash peaked at $80.3 million during Q4 2022, and registered a low of -$103.4 million during Q2 2023.
  • Over the past 4 years, Terns Pharmaceuticals' median Change in Cash value was -$1.7 million (recorded in 2020), while the average stood at $4.2 million.
  • Within the past 5 years, the most significant YoY rise in Terns Pharmaceuticals' Change in Cash was 389952.46% (2021), while the steepest drop was 49574.36% (2021).
  • Over the past 4 years, Terns Pharmaceuticals' Change in Cash (Quarter) stood at $61.0 million in 2020, then plummeted by 127.93% to -$17.1 million in 2021, then soared by 570.67% to $80.3 million in 2022, then crashed by 47.63% to $42.0 million in 2023.
  • Its last three reported values are $42.0 million in Q4 2023, -$43.0 million for Q3 2023, and -$103.4 million during Q2 2023.